Image_6_Cytotoxic CD8+ T Cells Expressing CXCR5 Are Detectable in HIV-1 Elite Controllers After Prolonged In Vitro Peptide Stimulation.tif
Antiretroviral therapy (ART) is not curative as HIV-1 persists in long-lived viral reservoirs. Consequently, patients are dependent on life-long drug adherence with possible side effects. To overcome these limitations strategies of a functional cure aim at ART free viral remission. In this study, we sought to identify detailed subsets of anti-viral CD8+ T cell immunity linked to natural long-term control of HIV-1 infection. Here, we analyzed HIV controllers and ART suppressed progressors for in vitro viral suppressive capacity (VSC) at baseline and after peptide stimulation. Functional properties and phenotypes of CD8+ T cells were assessed by IFN-γ ELISPOT and 18 color flow cytometry. HIV controllers showed significantly increased suppression at baseline as well as after peptide stimulation. IFN-γ secretion and the proliferation marker Ki67 positively correlated with VSC. Moreover, the detailed phenotype of three distinct multifunctional memory CD8+ T cell subsets were specific traits of HIV controllers of which two correlated convincingly with VSC. Our results underline the importance of multifunctional CD8+ T cell responses during natural control. Especially the role of CXCR5 expressing cytotoxic subsets emphasizes potential surveillance in sites of reservoir persistence and demand further study.
History
References
- https://doi.org//10.1126/science.278.5341.1295
- https://doi.org//10.1056/nejmoa062360
- https://doi.org//10.1097/QAD.0000000000000987
- https://doi.org//10.1097/QAD.0000000000000049
- https://doi.org//10.1371/journal.pmed.0030403
- https://doi.org//10.1126/science.1143767
- https://doi.org//10.1126/science.1195271
- https://doi.org//10.1182/blood-2010-12-322727
- https://doi.org//10.1016/j.immuni.2008.10.010
- https://doi.org//10.1038/ni845
- https://doi.org//10.1128/JVI.01754-06
- https://doi.org//10.1182/blood-2005-12-4818
- https://doi.org//10.1097/QAI.0b013e3181e69609
- https://doi.org//10.3389/fimmu.2013.00086
- https://doi.org//10.1111/imr.12083
- https://doi.org//10.1128/jvi.76.5.2298-2305.2002
- https://doi.org//10.1128/JVI.07034-11
- https://doi.org//10.1128/JVI.00803-10
- https://doi.org//10.1128/JVI.00286-10
- https://doi.org//10.1371/journal.ppat.1002529
- https://doi.org//10.1038/nm1461
- https://doi.org//10.1128/JVI.02176-07
- https://doi.org//10.1086/526786
- https://doi.org//10.1128/JVI.00419-16
- https://doi.org//10.1097/QAI.0b013e318224d2e9
- https://doi.org//10.1371/journal.pone.0059767
- https://doi.org//10.1128/JVI.02031-09
- https://doi.org//10.4049/jimmunol.0803928
- https://doi.org//10.1093/infdis/jis379
- https://doi.org//10.1097/QAD.0000000000002068
- https://doi.org//10.3389/fimmu.2019.01842
- https://doi.org//10.1016/j.celrep.2017.11.075
- https://doi.org//10.1073/pnas.1621418114
- https://doi.org//10.1086/650492
- https://doi.org//10.1038/s41598-018-35403-6
- https://doi.org//10.1016/j.jviromet.2006.11.012
- https://doi.org//10.1128/JVI.02165-06
- https://doi.org//10.1073/pnas.0611244104
- https://doi.org//10.1128/JVI.00437-12
- https://doi.org//10.1016/S0022-1759(03)00226-6
- https://doi.org//10.1016/j.jim.2016.04.010
- https://doi.org//10.1128/JVI.00276-16
- https://doi.org//10.1016/j.vaccine.2006.06.009
- https://doi.org//10.1038/nm.2089
- https://doi.org//10.1128/JVI.02260-07
- https://doi.org//10.1038/nm1520
- https://doi.org//10.1038/nature07469
- https://doi.org//10.4049/jimmunol.178.5.2746
- https://doi.org//10.1128/JVI.02131-12
- https://doi.org//10.1016/j.immuni.2012.01.014
- https://doi.org//10.1128/JVI.00865-13
- https://doi.org//10.1128/JVI.80.6.3122-3125.2006
- https://doi.org//10.1128/JVI.02073-08
- https://doi.org//10.1128/JVI.00138-10
- https://doi.org//10.1038/nri3596
- https://doi.org//10.1084/jem.20070784
- https://doi.org//10.1097/QAI.0000000000001700
- https://doi.org//10.1084/jem.20121932
- https://doi.org//10.1038/nm.4113
- https://doi.org//10.1016/j.celrep.2017.11.075
- https://doi.org//10.1126/scitranslmed.aag2285
- https://doi.org//10.7554/eLife.57246
- https://doi.org//10.1172/JCI97555
Usage metrics
Read the peer-reviewed publication
Categories
- Transplantation Immunology
- Tumour Immunology
- Immunology not elsewhere classified
- Immunology
- Veterinary Immunology
- Animal Immunology
- Genetic Immunology
- Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies)
- Autoimmunity
- Cellular Immunology
- Humoural Immunology and Immunochemistry
- Immunogenetics (incl. Genetic Immunology)
- Innate Immunity